George A. Ward

1.6k total citations
30 papers, 894 citations indexed

About

George A. Ward is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, George A. Ward has authored 30 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Immunology and 9 papers in Cancer Research. Recurrent topics in George A. Ward's work include Ubiquitin and proteasome pathways (10 papers), Cell death mechanisms and regulation (5 papers) and Peptidase Inhibition and Analysis (5 papers). George A. Ward is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Cell death mechanisms and regulation (5 papers) and Peptidase Inhibition and Analysis (5 papers). George A. Ward collaborates with scholars based in United Kingdom, United States and Japan. George A. Ward's co-authors include Karen Miller, A. J. H. Gearing, John M. Clements, Judy Cossins, Grahame J. McKenzie, Graham Wells, Brian Champion, L M Wood, R Pigott and Dominic J. Corkill and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

George A. Ward

29 papers receiving 853 citations

Peers

Countries citing papers authored by George A. Ward

Since Specialization

Citations

This map shows the geographic impact of George A. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George A. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George A. Ward more than expected).

Fields of papers citing papers by George A. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George A. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George A. Ward. The network helps show where George A. Ward may publish in the future.

Co-authorship network of co-authors of George A. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of George A. Ward. A scholar is included among the top collaborators of George A. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George A. Ward. George A. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The IAP antagonist tolinapant enhances the anti-tumor activity of cell therapies 2025 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), (unknown), Martin Sims, George A. Ward, Tomoko Smyth, Hironori Matsuyama, Toshiki Sudo	0
2	Epigenetic Priming by Hypomethylation Enhances the Immunogenic Potential of Tolinapant in T-cell Lymphoma 2024 ·Cancer Research Communications ·George A. Ward, Zhiqiang Zhang, Simone Jueliger, (unknown), Matthew P. Davis, (unknown), (unknown), Harold Keer, (unknown), John F. Lyons, Martin Sims, Tomoko Smyth	2
3	Proteome-wide CETSA reveals diverse apoptosis-inducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery 2024 ·Cell Reports ·(unknown), Ying Liang, Olga Surova, Silviu‐Alin Bacanu, (unknown), Tamoghna Mandal, Sophia Ceder, (unknown), (unknown), George A. Ward, Jonas Bergh, Klas G. Wiman, Sören Lehmann, Nayana Prabhu, Sara Lööf, P. Nordlund	2
4	Imaging of Light-Enhanced Extracellular Vesicle-Mediated Delivery of Oxaliplatin to Colorectal Cancer Cells via Laser Ablation, Inductively Coupled Plasma Mass Spectrometry 2023 ·Cells ·(unknown), (unknown), George A. Ward, (unknown), Thomas P. White, (unknown), (unknown), Keith Chapple, (unknown), (unknown), (unknown), Sarah Haywood‐Small, Simon Turega, Nicholas Peake	4
5	Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma 2021 ·Blood Advances ·Nicola Ferrari, George A. Ward, Christina Gewinner, Matthew P. Davis, Simone Jueliger, Harpreet K. Saini, Joanne M. Munck, Tomoko Smyth, Roberta Ferraldeschi, Harold Keer, John F. Lyons, Martin Sims	5
6	Abstract 5542: ASTX660, a non-peptidomimetic antagonist of cIAP1/2 and XIAP, enhances immune mediated tumor killing and induction of immunogenic cell death 2020 ·Cancer Research ·Nicola Ferrari, George A. Ward, Joanne M. Munck, Simone Jueliger, Matthew Davis, Christina Gewinner, Roberta Ferraldeschi, John C. Lyons, Martin Sims	1
7	Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways 2019 ·Cell Death and Differentiation ·(unknown), (unknown), Patrick Metzger, George A. Ward, Melanie Boerries, Meike Vogler, Simone Fulda	11
8	ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth 2018 ·Molecular Cancer Therapeutics ·George A. Ward, Edward J. Lewis, Jong Sook Ahn, Christopher N. Johnson, John F. Lyons, (unknown), Joanne M. Munck, Sharna J. Rich, Tomoko Smyth, Neil T. Thompson, Pamela A. Williams, Nicola E. Wilsher, Nicola G. Wallis, Gianni Chessari	53
9	Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP) 2017 ·Journal of Medicinal Chemistry ·Emiliano Tamanini, Ildiko M. Buck, Gianni Chessari, Elisabetta Chiarparin, James E. H. Day, Martyn Frederickson, Charlotte Griffiths-Jones, Keisha Hearn, Tom D. Heightman, Aman Iqbal, Christopher N. Johnson, Edward J. Lewis, Vanessa Martins, Torren M. Peakman, Michael Reader, Sharna J. Rich, George A. Ward, Pamela A. Williams, Nicola E. Wilsher	57
10	PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy 2016 ·Oncotarget ·(unknown), Pamela Maxwell, Chee Wee Ong, Kelly M. Redmond, Christopher McCann, (unknown), George A. Ward, Gianni Chessari, Christopher Johnson, Nyree Crawford, Melissa J. LaBonte, Kevin M. Prise, Tracy Robson, Manuel Salto‐Tellez, Daniel B. Longley, David Waugh	32
11	Abstract 1287: The dual IAP antagonist, ASTX660, increases the anti-tumor activity of paclitaxel in preclinical models of triple-negative breast cancer in vivo 2016 ·Cancer Research ·Tomoko Smyth, Yoko Nakatsuru, (unknown), George A. Ward, Luke Bevan, Jon Lewis, Nicola G. Wallis, John C. Lyons	1
12	Abstract 1738: JNJ-42756493 is an inhibitor of FGFR-1, 2, 3 and 4 with nanomolar affinity for targeted therapy 2014 ·Cancer Research ·Timothy Perera, (unknown), Jorge Vialard, Tinne Verhulst, N. Esser, Berthold Wroblowski, Ron Gilissen, Eddy Freyne, Peter King, Suso Platero, Olivier Querolle, Laurence Mévellec, Christopher W. Murray, Lynsey Fazal, Gordon Saxty, George A. Ward, Matthew Squires, Neil T. Thompson, David R. Newell, Patrick Angibaud	8
13	SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma 2013 ·Cell Death and Disease ·Nyree Crawford, (unknown), Caitriona Holohan, Joanna Majkut, Michael McGrath, Patrick G. Johnston, Gianni Chessari, George A. Ward, David Waugh, Dean A. Fennell, Daniel B. Longley	31
14	85 Characterization of a Potent XIAP and CIAP1 Dual Antagonist in Models of Melanoma and Leukemia 2012 ·European Journal of Cancer ·N. Thompson, Mok‐Ryeon Ahn, Gianni Chessari, (unknown), Christopher N. Johnson, Jon Lewis, George A. Ward, Philip G. Williams, Alison J.‐A. Woolford	3
15	Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals 2006 ·BMC Cell Biology ·Grahame J. McKenzie, George A. Ward, Yvette Stallwood, Emmanuel Briend, Sofia Papadia, Andrew C. Lennard, Martin Turner, Brian Champion, Giles E. Hardingham	67
16	Nuclear Ca²⁺ and CaM kinase IV specify hormonal‐ and Notch‐responsiveness 2005 ·Journal of Neurochemistry ·Grahame J. McKenzie, (unknown), George A. Ward, Sofia Papadia, Hilmar Bading, Sangeeta Chawla, Martin L. Privalsky, Giles E. Hardingham	49
17	Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell–dependent mechanism 2003 ·Journal of Clinical Investigation ·Kenneth K. Wong, Matthew J. Carpenter, Lesley Young, Susan J. Walker, Grahame J. McKenzie, (unknown), George A. Ward, (unknown), (unknown), Luc Delrivière, Gerard F. Hoyne, Paul Gibbs, Brian Champion, Jonathan R. Lamb, Margaret J. Dallman	63
18	Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin 2002 ·Immunology Letters ·A. J. H. Gearing, Susan J. Thorpe, Karen Miller, (unknown), Paul Varley, (unknown), George A. Ward, (unknown), Robin Thorpe	62
19	Extracellular matrix-mediated chemotaxis can impede cell migration 1998 ·Proceedings of the Royal Society B Biological Sciences ·Abbey J. Perumpanani, David L. Simmons, A. J. H. Gearing, Karen Miller, George A. Ward, John W. Norbury, Markus Schneemann, Jonathan A. Sherratt	40
20	Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor 1997 ·Journal of Neuroimmunology ·John M. Clements, Judy Cossins, Graham Wells, Dominic J. Corkill, (unknown), L M Wood, R Pigott, (unknown), George A. Ward, A. J. H. Gearing, Karen Miller	174

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact